VANOS Drug Patent Profile
✉ Email this page to a colleague
When do Vanos patents expire, and when can generic versions of Vanos launch?
Vanos is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in VANOS is fluocinonide. There are nine drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the fluocinonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vanos
A generic version of VANOS was approved as fluocinonide by TEVA on December 27th, 1991.
Summary for VANOS
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 72 |
Patent Applications: | 4,374 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for VANOS |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for VANOS |
What excipients (inactive ingredients) are in VANOS? | VANOS excipients list |
DailyMed Link: | VANOS at DailyMed |
Pharmacology for VANOS
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for VANOS
Paragraph IV (Patent) Challenges for VANOS
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
VANOS | Cream | fluocinonide | 0.1% | 021758 | 1 | 2008-01-31 |
US Patents and Regulatory Information for VANOS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | VANOS | fluocinonide | CREAM;TOPICAL | 021758-001 | Feb 11, 2005 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VANOS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch | VANOS | fluocinonide | CREAM;TOPICAL | 021758-001 | Feb 11, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | VANOS | fluocinonide | CREAM;TOPICAL | 021758-001 | Feb 11, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | VANOS | fluocinonide | CREAM;TOPICAL | 021758-001 | Feb 11, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | VANOS | fluocinonide | CREAM;TOPICAL | 021758-001 | Feb 11, 2005 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VANOS
See the table below for patents covering VANOS around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
World Intellectual Property Organization (WIPO) | 03055445 | ⤷ Sign Up | |
Canada | 2471041 | COMPOSITIONS ET PROCEDES FAVORISANT L'ADMINISTRATION DE CORTICOSTEROIDES (COMPOSITIONS AND METHODS FOR ENHANCING CORTICOSTERIOD DELIVERY) | ⤷ Sign Up |
Israel | 162581 | ⤷ Sign Up | |
Japan | 2010280689 | COMPOSITION AND METHOD FOR ENHANCING CORTICOSTEROID DELIVERY | ⤷ Sign Up |
European Patent Office | 1465636 | ⤷ Sign Up | |
Australia | 2002360589 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |